A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.


Journal

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
ISSN: 1873-5010
Titre abrégé: J Cyst Fibros
Pays: Netherlands
ID NLM: 101128966

Informations de publication

Date de publication:
05 2020
Historique:
received: 20 04 2020
revised: 22 04 2020
accepted: 22 04 2020
pubmed: 8 5 2020
medline: 10 7 2020
entrez: 8 5 2020
Statut: ppublish

Résumé

Information is lacking on the clinical impact of the novel coronavirus, SARS-CoV-2, on people with cystic fibrosis (CF). Our aim was to characterise SARS-CoV-2 infection in people with cystic fibrosis. Anonymised data submitted by each participating country to their National CF Registry was reported using a standardised template, then collated and summarised. 40 cases have been reported across 8 countries. Of the 40 cases, 31 (78%) were symptomatic for SARS-CoV-2 at presentation, with 24 (60%) having a fever. 70% have recovered, 30% remain unresolved at time of reporting, and no deaths have been submitted. This early report shows good recovery from SARS-CoV-2 in this heterogeneous CF cohort. The disease course does not seem to differ from the general population, but the current numbers are too small to draw firm conclusions and people with CF should continue to strictly follow public health advice to protect themselves from infection.

Identifiants

pubmed: 32376098
pii: S1569-1993(20)30125-9
doi: 10.1016/j.jcf.2020.04.012
pmc: PMC7183287
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

355-358

Investigateurs

David Reid (D)
Peter Wark (P)
Géraldine Daneau (G)
Véronique Boussaud (V)
Graziella Brinchault (G)
Emmanuelle Coirier-Duet (E)
Jean-Christophe Dubus (JC)
Dominique Grenet (D)
Sandra de Miranda (S)
Laurence Beaumont (L)
Reem Kanaan (R)
Muriel Lauraens (M)
Clémence Martin (C)
Marie Mittaine (M)
Anne Prévotat (A)
Martine Reynaud-Gaubert (M)
Isabelle Sermet-Gaudelus (I)
Aurelie Tatopoulos (A)
Lutz Nährlich (L)
Barry Plant (B)
Cedric Gunaratnam (C)
Abaigeal Jackson (A)
Karin M de Winter-de Groot (KMW)
Bart Luijk (B)
Geertjan Wesseling (G)
Mark Allenby (M)
Jamie Duckers (J)
Elaine Gunn (E)
Andrew Jones (A)
Robert Ian Ketchell (RI)
Susan L Madge (SL)
Anirban Maitra (A)
Ghulam Mujtaba (G)
Helen Rodgers (H)
Nadia Shafi (N)
Nicholas Simmonds (N)
Kevin Southern (K)
Danie Watson (D)
Samar Rizvi (S)
Julie Seguin (J)
Janet Garbarz (J)
Kristen Rosamilia (K)
Maria Berdella (M)
Jerry A Nick (JA)
Richard Belkin (R)
Diana Gilmore (D)
Kim McBennett (K)
Rita Padoan (R)
Marco Salvatore (M)

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts of interest to declare relating to this work.

Références

N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Lancet. 2019 Nov 23;394(10212):1940-1948
pubmed: 31679946
J Cyst Fibros. 2011 Sep;10(5):370-6
pubmed: 21752728
Lancet Respir Med. 2020 May;8(5):436-438
pubmed: 32251625
Korean J Radiol. 2020 Apr;21(4):505-508
pubmed: 32174053
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632

Auteurs

Rebecca Cosgriff (R)

Cystic Fibrosis Trust, London, UK. Electronic address: rebecca.cosgriff@cysticfibrosis.org.uk.

Susannah Ahern (S)

Monash University, Melbourne, Australia.

Scott C Bell (SC)

The Prince Charles Hospital, Brisbane, Australia.

Keith Brownlee (K)

Cystic Fibrosis Trust, London, UK.

Pierre-Régis Burgel (PR)

Université de Paris, Inserm U1016, Institut Cochin and Cochin Hospital, Assistance Publique Hôpitaux de Paris (APHP).

Cass Byrnes (C)

University of Auckland, Auckland, New Zealand.

Harriet Corvol (H)

Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, Assistance Publique Hôpitaux de Paris (APHP), Hôpital Trousseau, Service de Pneumologie Pédiatrique, Paris, France.

Stephanie Y Cheng (SY)

Cystic Fibrosis Canada, Toronto, Canada.

Alexander Elbert (A)

Cystic Fibrosis Foundation, Bethesda, US.

Albert Faro (A)

Cystic Fibrosis Foundation, Bethesda, US.

Christopher H Goss (CH)

University of Washington, Seattle, US.

Vincent Gulmans (V)

Dutch CF Foundation NCFS, Baarn, Netherlands.

Bruce C Marshall (BC)

Cystic Fibrosis Foundation, Bethesda, US.

Edward McKone (E)

St Vincent's University Hospital, Dublin, Ireland.

Peter G Middleton (PG)

Westmead Hospital, Sydney, Australia.

Rasa Ruseckaite (R)

Monash University, Melbourne, Australia.

Anne L Stephenson (AL)

Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, Assistance Publique Hôpitaux de Paris (APHP), Hôpital Trousseau, Service de Pneumologie Pédiatrique, Paris, France; Toronto Adult Cystic Fibrosis Centre, St. Michael's Hospital, Toronto, Canada.

Siobhán B Carr (SB)

Royal Brompton Hospital and Imperial College London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH